Abstract
Persistent human Papillomavirus (HPV) infections are now recognised as the leading cause of cervical cancer (CC). Approximately 100 types of human infecting HPV exist in nature and according to the samples collected from either pre-cancerous or cancerous lesions, almost ten are responsible for a good part of the CC cases. Two anti-HPV vaccines are currently registered worldwide - a tetravalent and a bivalent one - for which evidences of protecting effectiveness and safety have been delivered by controlled clinical trials and clinical practice. Consequently, and as a first step, several countries implemented HPV mass vaccination programmes for girls before the age of sexual debut. Moreover, and specifically for the bivalent vaccine, efficacy over various oncogenic types has been demonstrated in a broad population also including sexually active women that had potentially already acquired an HPV infection. The opportunity to extend the primary prevention to other cohorts of women up to the adult age through the use of the vaccine, improves the possibility to actively reduce the total number of CC cases. Based on two country examples, Italy and Belgium, different strategies for HPV vaccination of pre-adolescents, adolescents and young adults are discussed.
Keywords: Papillomavirus, anti-HPV vaccines, primary prevention, pre-adolescents, adolescents, young adults, immunogenic effects
Current Cancer Therapy Reviews
Title: HPV Vaccination in Adolescents: From Clinical Data to Implementation and Practice
Volume: 6 Issue: 2
Author(s): Franco Borruto and Karel Hoppenbrouwers
Affiliation:
Keywords: Papillomavirus, anti-HPV vaccines, primary prevention, pre-adolescents, adolescents, young adults, immunogenic effects
Abstract: Persistent human Papillomavirus (HPV) infections are now recognised as the leading cause of cervical cancer (CC). Approximately 100 types of human infecting HPV exist in nature and according to the samples collected from either pre-cancerous or cancerous lesions, almost ten are responsible for a good part of the CC cases. Two anti-HPV vaccines are currently registered worldwide - a tetravalent and a bivalent one - for which evidences of protecting effectiveness and safety have been delivered by controlled clinical trials and clinical practice. Consequently, and as a first step, several countries implemented HPV mass vaccination programmes for girls before the age of sexual debut. Moreover, and specifically for the bivalent vaccine, efficacy over various oncogenic types has been demonstrated in a broad population also including sexually active women that had potentially already acquired an HPV infection. The opportunity to extend the primary prevention to other cohorts of women up to the adult age through the use of the vaccine, improves the possibility to actively reduce the total number of CC cases. Based on two country examples, Italy and Belgium, different strategies for HPV vaccination of pre-adolescents, adolescents and young adults are discussed.
Export Options
About this article
Cite this article as:
Borruto Franco and Hoppenbrouwers Karel, HPV Vaccination in Adolescents: From Clinical Data to Implementation and Practice, Current Cancer Therapy Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339410791202592
DOI https://dx.doi.org/10.2174/157339410791202592 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vivo Pharmacokinetic and Tissue Distribution Studies in Mice of Alternative Formulations for Local and Systemic Delivery of Paclitaxel: Gel, Film, Prodrug, Liposomes and Micelles
Current Drug Delivery Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies
Anti-Cancer Agents in Medicinal Chemistry Fundamentals of Nanocarriers and Probiotics in the Treatment of Cervical Cancer
Current Nanomedicine Appropriate Use of Antibiotics for the Management of Respiratory Tract Infections
Infectious Disorders - Drug Targets Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases
Current Medicinal Chemistry E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry A Review of Himalayan Medicinal Plants against Cancer
Current Traditional Medicine An Evaluation of Computational Learning-based Methods for the Segmentation of Nuclei in Cervical Cancer Cells from Microscopic Images
Current Computer-Aided Drug Design Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy
Current Topics in Medicinal Chemistry Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders
Current Pharmaceutical Design Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
Recent Patents on Anti-Cancer Drug Discovery Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Overview of the Metallometabolomic Methodology for Metal-Based Drug Metabolism
Current Drug Metabolism